E. Ohman J:Or Asset Management Ab Sarepta Therapeutics, Inc. Transaction History

E. Ohman J:Or Asset Management Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 05, 2024	SELL	$72.25 - $168.95 $8.42 Million - $19.7 Million	-116,600 Closed	0 $0
Q4 2020 Apr 05, 2024	SELL	$125.56 - $178.74 $226,008 - $321,732	-1,800 Reduced 1.52%	116,600 $19.9 Billion
Q3 2020 Apr 05, 2024	SELL	$127.12 - $172.34 $2.95 Million - $4 Million	-23,200 Reduced 16.38%	118,400 $16.6 Billion
Q2 2020 Apr 05, 2024	BUY	$93.0 - $171.7 $1.68 Million - $3.11 Million	18,100 Added 14.66%	141,600 $22.7 Billion
Q1 2020 Apr 05, 2024	BUY	$82.38 - $131.64 $350,115 - $559,470	4,250 Added 3.56%	123,500 $12.1 Billion

Q4 2019 Apr 05, 2024	BUY	$76.53 - $135.58 $9.13 Million - $16.2 Million	119,250 New	119,250 $15.4 Billion

470

79.3M

4.23M

1.21M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.